Corneal nerve fiber loss relates to cognitive impairment in patients with Parkinson’s disease

Abstract Cognitive impairment in Parkinson’s disease (PD) adversely influences quality of life. There is currently no available biomarker to predict cognitive decline in PD. Corneal confocal microscopy (CCM) has been used as a non-invasive tool for quantifying small nerve damage in PD. The present s...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ning-Ning Che, Qiu-Huan Jiang, Guan-Xiao Ding, Si-Yuan Chen, Zhen-Xiang Zhao, Xue Li, Rayaz A. Malik, Jian-Jun Ma, Hong-Qi Yang
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Acceso en línea:https://doaj.org/article/f0cf9edbf35a4feda31db5a970887a13
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f0cf9edbf35a4feda31db5a970887a13
record_format dspace
spelling oai:doaj.org-article:f0cf9edbf35a4feda31db5a970887a132021-12-02T17:19:18ZCorneal nerve fiber loss relates to cognitive impairment in patients with Parkinson’s disease10.1038/s41531-021-00225-32373-8057https://doaj.org/article/f0cf9edbf35a4feda31db5a970887a132021-09-01T00:00:00Zhttps://doi.org/10.1038/s41531-021-00225-3https://doaj.org/toc/2373-8057Abstract Cognitive impairment in Parkinson’s disease (PD) adversely influences quality of life. There is currently no available biomarker to predict cognitive decline in PD. Corneal confocal microscopy (CCM) has been used as a non-invasive tool for quantifying small nerve damage in PD. The present study investigated whether corneal nerve measures were associated with cognitive function in PD. Patients with PD were classified into those with normal cognitive function (PD-CN), mild cognitive impairment (PD-MCI), and dementia (PDD). Corneal nerve fiber density (CNFD), corneal nerve branch density (CNBD), and corneal nerve fiber length (CNFL) were quantified with CCM and compared with a control group. Sixty-five PD patients and thirty controls were studied. CNFD was decreased and CNBD was increased in PD patients compared to controls (P < 0.05). CNBD and CNBD/CNFD ratio was higher in PD-CN compared to controls. CNFD was positively correlated with the Montreal cognitive assessment (MoCA) score (r = 0.683, P < 0.001), but negatively associated with unified Parkinson disease rating scale (UPDRS)-part III (r = −0.481, P < 0.001) and total UPDRS scores (r = −0.401, P = 0.001) in PD patients. There was no correlation between CNFD and Levodopa equivalent daily dose (LEDD) (r = 0.176, P = 0.161). CNFD, CNBD, CNFL, and CNBD/CNFD ratio was lower with increasing Hoehn and Yahr stage. PD patients show evidence of corneal nerve loss compared with controls and corneal nerve parameters are associated with the severity of cognitive and motor dysfunction in PD. CCM could serve as an objective in vivo ophthalmic imaging technique to assess neurodegeneration in PD.Ning-Ning CheQiu-Huan JiangGuan-Xiao DingSi-Yuan ChenZhen-Xiang ZhaoXue LiRayaz A. MalikJian-Jun MaHong-Qi YangNature PortfolioarticleNeurology. Diseases of the nervous systemRC346-429ENnpj Parkinson's Disease, Vol 7, Iss 1, Pp 1-9 (2021)
institution DOAJ
collection DOAJ
language EN
topic Neurology. Diseases of the nervous system
RC346-429
spellingShingle Neurology. Diseases of the nervous system
RC346-429
Ning-Ning Che
Qiu-Huan Jiang
Guan-Xiao Ding
Si-Yuan Chen
Zhen-Xiang Zhao
Xue Li
Rayaz A. Malik
Jian-Jun Ma
Hong-Qi Yang
Corneal nerve fiber loss relates to cognitive impairment in patients with Parkinson’s disease
description Abstract Cognitive impairment in Parkinson’s disease (PD) adversely influences quality of life. There is currently no available biomarker to predict cognitive decline in PD. Corneal confocal microscopy (CCM) has been used as a non-invasive tool for quantifying small nerve damage in PD. The present study investigated whether corneal nerve measures were associated with cognitive function in PD. Patients with PD were classified into those with normal cognitive function (PD-CN), mild cognitive impairment (PD-MCI), and dementia (PDD). Corneal nerve fiber density (CNFD), corneal nerve branch density (CNBD), and corneal nerve fiber length (CNFL) were quantified with CCM and compared with a control group. Sixty-five PD patients and thirty controls were studied. CNFD was decreased and CNBD was increased in PD patients compared to controls (P < 0.05). CNBD and CNBD/CNFD ratio was higher in PD-CN compared to controls. CNFD was positively correlated with the Montreal cognitive assessment (MoCA) score (r = 0.683, P < 0.001), but negatively associated with unified Parkinson disease rating scale (UPDRS)-part III (r = −0.481, P < 0.001) and total UPDRS scores (r = −0.401, P = 0.001) in PD patients. There was no correlation between CNFD and Levodopa equivalent daily dose (LEDD) (r = 0.176, P = 0.161). CNFD, CNBD, CNFL, and CNBD/CNFD ratio was lower with increasing Hoehn and Yahr stage. PD patients show evidence of corneal nerve loss compared with controls and corneal nerve parameters are associated with the severity of cognitive and motor dysfunction in PD. CCM could serve as an objective in vivo ophthalmic imaging technique to assess neurodegeneration in PD.
format article
author Ning-Ning Che
Qiu-Huan Jiang
Guan-Xiao Ding
Si-Yuan Chen
Zhen-Xiang Zhao
Xue Li
Rayaz A. Malik
Jian-Jun Ma
Hong-Qi Yang
author_facet Ning-Ning Che
Qiu-Huan Jiang
Guan-Xiao Ding
Si-Yuan Chen
Zhen-Xiang Zhao
Xue Li
Rayaz A. Malik
Jian-Jun Ma
Hong-Qi Yang
author_sort Ning-Ning Che
title Corneal nerve fiber loss relates to cognitive impairment in patients with Parkinson’s disease
title_short Corneal nerve fiber loss relates to cognitive impairment in patients with Parkinson’s disease
title_full Corneal nerve fiber loss relates to cognitive impairment in patients with Parkinson’s disease
title_fullStr Corneal nerve fiber loss relates to cognitive impairment in patients with Parkinson’s disease
title_full_unstemmed Corneal nerve fiber loss relates to cognitive impairment in patients with Parkinson’s disease
title_sort corneal nerve fiber loss relates to cognitive impairment in patients with parkinson’s disease
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/f0cf9edbf35a4feda31db5a970887a13
work_keys_str_mv AT ningningche cornealnervefiberlossrelatestocognitiveimpairmentinpatientswithparkinsonsdisease
AT qiuhuanjiang cornealnervefiberlossrelatestocognitiveimpairmentinpatientswithparkinsonsdisease
AT guanxiaoding cornealnervefiberlossrelatestocognitiveimpairmentinpatientswithparkinsonsdisease
AT siyuanchen cornealnervefiberlossrelatestocognitiveimpairmentinpatientswithparkinsonsdisease
AT zhenxiangzhao cornealnervefiberlossrelatestocognitiveimpairmentinpatientswithparkinsonsdisease
AT xueli cornealnervefiberlossrelatestocognitiveimpairmentinpatientswithparkinsonsdisease
AT rayazamalik cornealnervefiberlossrelatestocognitiveimpairmentinpatientswithparkinsonsdisease
AT jianjunma cornealnervefiberlossrelatestocognitiveimpairmentinpatientswithparkinsonsdisease
AT hongqiyang cornealnervefiberlossrelatestocognitiveimpairmentinpatientswithparkinsonsdisease
_version_ 1718381059276537856